25th Annual Meeting | May 16-19, 2022

Learn More

On Demand: Deep-Dive Sessions on AAV, Long COVID

ASGCT's Insight Series events on AAV vector design, immune responses, and more, are available for Members and registrants to watch on demand!

Upcoming Opportunities

April 28: Lunch & Learn on AAV Vector Manufacturing

We often hear that gene therapies are complex and require a lot of time and money to make. But what does that really mean? Tune in to hear experts in the field help answer this question.

May 16-19: 25th Annual Meeting

Join us in Washington, D.C. for the 25th Annual Meeting May 16-19! Early registration ends Feb. 28.

Meeting, Workshop, & Course Information

ASGCT Annual Meetings

The annual meeting provides a forum for professionals to present and critically discuss the latest gene and cell therapy developments.

Professional Development Cafés

Our series of professional development cafés  will be free live and on demand for ASGCT members. Register now for Critical CMC Issues for Gene and Cell Therapy Products on Dec. 3!

Pre-Meeting Workshops

Learn more about the ASGCT Pre-Meeting Workshops, traditionally held the day before the ASGCT Annual Meeting.


We've partnered with the National Organization for Rare Disorders to create a series of digital events designed to educate both patient and clinical audiences about the potential of gene therapy.

Non-ASGCT Events

Find out about other gene and cell therapy events throughout the year. 

ASGCT Discrimination & Harassment Policy

The fields of gene and cell therapy will be strongest when all members are supported by positive, safe, and healthy work environments. Our hope is that this policy will prevent incidents of harassment and discrimination, remove barriers to reporting incidents, and maintain the high quality of scientific discourse that we have come to expect at ASGCT events.


ASGCT 25th Annual Meeting

May 16-19, 2022

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.